Close

Medicago to develop new VLP vaccine candidate for rabies

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing...

AI in Specialty Chemicals is Advancing Innovation

The pharmaceutical specialty chemical industry is in the process...

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation...

Medicago, a biotechnology company, has completed initial studies towards the development of a new VLP vaccine candidate for rabies.

The initial studies with rabies VLP vaccine demonstrated that two doses of one or four micrograms induced protective levels of neutralizing antibodies in a mouse model. The company expects to move ahead with GMP process development and a GLP toxicology study in 2012 and a Phase I clinical trial.

Medicago president and CEO Andrew Sheldon said that they see significant potential for our technologies in the development of VLP vaccines and biosimilars. “The rabies virus is a significant problem where current vaccines present challenges to access due to availability and cost, which we believe our VLP vaccine could address,” Sheldon added.

Latest stories

Related stories

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing...

AI in Specialty Chemicals is Advancing Innovation

The pharmaceutical specialty chemical industry is in the process...

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back